Polytherics Lands $20.8M to Fund Antitope Acquisition

LONDON  Polytherics Ltd. raised £13.5 million (US$20.8 million) in a private round to fund the acquisition of antibody engineering specialist Antitope Ltd. and provide working capital to build on the enlarged company's portfolio of antibody development technologies.

To continue reading subscribe now to BioWorld Asia (formerly International)